Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Buccal Cavity Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06407518
What this trial is testing

Preoperative Oral Midazolam to Postoperative Pain Relief in Sleep Disturbance or Anxiety Patients With Colorectal Cancer

Who this might be right for
PreoperativeSleep DisturbanceAnxiety+2 more
Sixth Affiliated Hospital, Sun Yat-sen University 280
Early research (Phase 1)Study completedNCT00412997
What this trial is testing

LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma

Who this might be right for
TumorsCutaneous T-Cell Lymphoma
Novartis 14
Testing effectiveness (Phase 2)Study completedNCT01733797
What this trial is testing

Trismus Trial of Therabite vs Wooden Spatula in Head and Neck Cancer Patients

Who this might be right for
Oropharyngeal CancerOral Cancer
Brynn Chappell 71
Early research (Phase 1)Study completedNCT00773929
What this trial is testing

Safety Study of TAK-593 Given Orally in Subjects With Nonhematologic Advanced Cancer

Who this might be right for
Solid Tumors
Millennium Pharmaceuticals, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT00004256
What this trial is testing

Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer

Who this might be right for
Head and Neck CancerOral ComplicationsRadiation Toxicity
Royal Marsden NHS Foundation Trust
Testing effectiveness (Phase 2)Looking for participantsNCT07326566
What this trial is testing

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Who this might be right for
Glioblastoma (GBM)Newly Diagnosed GlioblastomaGBM+4 more
Black Diamond Therapeutics, Inc. 162
Large-scale testing (Phase 3)WithdrawnNCT01142414
What this trial is testing

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Not applicableStudy completedNCT02687087
What this trial is testing

Patients With Dry Mouth and Sticky Saliva During Radiotherapy

Who this might be right for
Xerostomia
NHS Greater Glasgow and Clyde 44
Testing effectiveness (Phase 2)Study completedNCT03427814
What this trial is testing

Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer

Who this might be right for
Advanced or Inoperable Gastric Cancer
BeiGene 136
Testing effectiveness (Phase 2)Study completedNCT00530621
What this trial is testing

Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Eli Lilly and Company 160
Large-scale testing (Phase 3)Study completedNCT00069121
What this trial is testing

Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 1,886
Testing effectiveness (Phase 2)Study completedNCT00886132
What this trial is testing

Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands

Who this might be right for
Adenoid Cystic CarcinomaSalivary Gland Cancer
University Health Network, Toronto 14
Early research (Phase 1)Not Yet RecruitingNCT06866795
What this trial is testing

Phase 1 Clinical Study of GT-220F in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Geode Therapeutics Inc. 42
Testing effectiveness (Phase 2)Study completedNCT01775475
What this trial is testing

Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma

Who this might be right for
AIDS-related Diffuse Large Cell LymphomaAIDS-related Diffuse Mixed Cell LymphomaAIDS-related Diffuse Small Cleaved Cell Lymphoma+6 more
AIDS Malignancy Consortium 7
Early research (Phase 1)Ended earlyNCT01975688
What this trial is testing

A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis

Who this might be right for
Head and Neck Squamous Cell Carcinoma
GW Pharmaceuticals Ltd 10
Early research (Phase 1)Looking for participantsNCT06046495
What this trial is testing

The Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Avistone Biotechnology Co., Ltd. 81
Post-approval studies (Phase 4)Study completedNCT00844675
What this trial is testing

Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection

Who this might be right for
Early Gastric AdenocarcinomaAdenocarcinoma, Tubular
The Catholic University of Korea 120
Testing effectiveness (Phase 2)Ended earlyNCT00242827
What this trial is testing

Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma

Who this might be right for
Myeloma
Cephalon
Post-approval studies (Phase 4)Study completedNCT07270146
What this trial is testing

Effectiveness and Safety of Guilu Erxian Oral Liquid in the Treatment of Oligozoospermia and Asthenospermia With Syndrome of Shen (Kidney) Essence Deficiency

Who this might be right for
Mild and Moderate Oligozoospermia Asthenospermia or Oligoasthenospermia and the Syndrome Differentiation Type is Shen (Kidney) Essence Deficiency
DongE E Jiao Coporation Limited 360
Testing effectiveness (Phase 2)Study completedNCT01274403
What this trial is testing

Study With Oral Melphalan + Prednisone (MP) Versus Melphalan, + Prednisone + Thalidomide (MPT) for Newly Diagnosesd Elderly Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Gruppo Italiano Studio Linfomi 130
Next Page